- Home
- LGCY vs TELA Comparison
LGCY vs TELA Comparison
Compare LGCY & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCY
- TELA
- Stock Information
- Founded
- LGCY 2009
- TELA 2012
- Country
- LGCY United States
- TELA United States
- Employees
- LGCY N/A
- TELA N/A
- Industry
- LGCY
- TELA Medical/Dental Instruments
- Sector
- LGCY
- TELA Health Care
- Exchange
- LGCY NYSE
- TELA Nasdaq
- Market Cap
- LGCY 67.3M
- TELA 61.8M
- IPO Year
- LGCY 2024
- TELA 2019
- Fundamental
- Price
- LGCY $5.77
- TELA $2.92
- Analyst Decision
- LGCY Strong Buy
- TELA Strong Buy
- Analyst Count
- LGCY 2
- TELA 4
- Target Price
- LGCY $8.48
- TELA $9.25
- AVG Volume (30 Days)
- LGCY 65.8K
- TELA 431.0K
- Earning Date
- LGCY 11-14-2024
- TELA 11-07-2024
- Dividend Yield
- LGCY N/A
- TELA N/A
- EPS Growth
- LGCY 90.87
- TELA N/A
- EPS
- LGCY 0.63
- TELA N/A
- Revenue
- LGCY $49,638,473.00
- TELA $68,649,000.00
- Revenue This Year
- LGCY N/A
- TELA $30.39
- Revenue Next Year
- LGCY N/A
- TELA $25.29
- P/E Ratio
- LGCY $10.34
- TELA N/A
- Revenue Growth
- LGCY 32.36
- TELA 29.34
- 52 Week Low
- LGCY $3.60
- TELA $2.30
- 52 Week High
- LGCY $7.83
- TELA $7.84
- Technical
- Relative Strength Index (RSI)
- LGCY N/A
- TELA 53.29
- Support Level
- LGCY N/A
- TELA $2.90
- Resistance Level
- LGCY N/A
- TELA $3.19
- Average True Range (ATR)
- LGCY 0.00
- TELA 0.19
- MACD
- LGCY 0.00
- TELA 0.01
- Stochastic Oscillator
- LGCY 0.00
- TELA 37.61
About LGCY LEGACY EDUCATION INC
Legacy Education Inc is engaged in career-focused, post-secondary education services to students at all stages of adult life, from recent high school graduates to working parents.
About TELA TELA Bio Inc.
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.